These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 33387518)

  • 21. Viral Dynamics of SARS-CoV-2 in Critically Ill Allogeneic Hematopoietic Stem Cell Transplant Recipients and Immunocompetent Patients with COVID-19.
    Roedl K; Heidenreich S; Pfefferle S; Jarczak D; Urbanowicz TT; Nörz D; Aepfelbacher M; Kröger N; Kluge S; Lütgehetmann M; Christopeit M; Wichmann D
    Am J Respir Crit Care Med; 2021 Jan; 203(2):242-245. PubMed ID: 33253054
    [No Abstract]   [Full Text] [Related]  

  • 22. Conversion from tacrolimus to Neoral in liver and kidney transplant recipients.
    Ott R; Bussenius-Kammerer M; Scholz D; Neuhaus R; Tolba RH; Fricke L; Müller V
    Transplant Proc; 2001; 33(7-8):3166-8. PubMed ID: 11750359
    [No Abstract]   [Full Text] [Related]  

  • 23. Tacrolimus-induced life-threatening arrhythmia in a pediatric liver-transplant patient.
    Nishimura M; Kim K; Uchiyama A; Fujino Y; Nishimura S; Taenaka N; Mashimo T
    Intensive Care Med; 2002 Nov; 28(11):1683-4. PubMed ID: 12583382
    [No Abstract]   [Full Text] [Related]  

  • 24. Characteristics of Liver Transplant Patients Infected with COVID-19.
    Regmi P; Liu F; Li FY
    Gastroenterology; 2021 Sep; 161(3):1068-1069.e1. PubMed ID: 33465372
    [No Abstract]   [Full Text] [Related]  

  • 25. Allergic disease after pediatric liver transplantation with systemic tacrolimus and cyclosporine a therapy.
    Arikan C; Kilic M; Tokat Y; Aydogdu S
    Transplant Proc; 2003 Dec; 35(8):3039-41. PubMed ID: 14697973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tacrolimus related hypertrophic cardiomyopathy in liver transplant recipients.
    Dehghani SM; Haghighat M; Imanieh MH; Zahmatkeshan M; Borzooei M; Amoozegar H; Zamirian M; Gholami S; Bahador A; Nikeghbalian S; Salahi H; Malek-Hosseini SA
    Arch Iran Med; 2010 Mar; 13(2):116-9. PubMed ID: 20187665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tacrolimus once-daily formulation: in the prophylaxis of transplant rejection in renal or liver allograft recipients.
    Cross SA; Perry CM
    Drugs; 2007; 67(13):1931-43. PubMed ID: 17722962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angioedema in pediatric liver transplant recipients under tacrolimus immunosuppression.
    Lykavieris P; Frauger E; Habes D; Bernard O; Debray D
    Transplantation; 2003 Jan; 75(1):152-55. PubMed ID: 12544888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
    Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gout in liver transplant patients receiving tacrolimus.
    Gerster JC; Dudler M; Halkic N; Gillet M
    Ann Rheum Dis; 2004 Jul; 63(7):894-5. PubMed ID: 15194597
    [No Abstract]   [Full Text] [Related]  

  • 31. Food protein sensitivity with partial villous atrophy after pediatric liver transplantation with tacrolimus immunosuppression.
    Blanchard SS; Gerrek M; Czinn S; Chelimsky G; Seaman D; Siegel C; Splawski J
    Pediatr Transplant; 2006 Jun; 10(4):529-32. PubMed ID: 16712617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sudden hearing loss associated with tacrolimus in a liver transplant recipient.
    Norman K; Bonatti H; Dickson RC; Aranda-Michel J
    Transpl Int; 2006 Jul; 19(7):601-3. PubMed ID: 16764642
    [No Abstract]   [Full Text] [Related]  

  • 33. Invasive fungal infections in liver transplant recipients receiving tacrolimus as the primary immunosuppressive agent.
    Singh N; Gayowski T; Wagener MM; Doyle H; Marino IR
    Clin Infect Dis; 1997 Feb; 24(2):179-84. PubMed ID: 9114144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Minimizing tacrolimus decreases the risk of new-onset diabetes mellitus after liver transplantation.
    Song JL; Gao W; Zhong Y; Yan LN; Yang JY; Wen TF; Li B; Wang WT; Wu H; Xu MQ; Chen ZY; Wei YG; Jiang L; Yang J
    World J Gastroenterol; 2016 Feb; 22(6):2133-41. PubMed ID: 26877618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trimetazidine counteracts tacrolimus nephrotoxicity in a hypertensive liver transplant patient.
    Zoppo A; Faggiotto A; Redaelli L; Campi S; Catapano AL
    Transplantation; 1999 Oct; 68(8):1211. PubMed ID: 10551656
    [No Abstract]   [Full Text] [Related]  

  • 36. Establishment of tacrolimus-induced diabetes in rat model and assessment of clinical treatments for post-transplant diabetes mellitus in liver transplant recipients.
    Niu YJ; Shen ZY; Xu C; Li CF; Liu XJ; Teng YQ; Chen H; Li L; Cheng HM; Yang XM; Mao S
    Clin Lab; 2013; 59(7-8):869-74. PubMed ID: 24133918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tacrolimus once-daily formulation in the prophylaxis of transplant rejection in renal or liver allograft recipients: a viewpoint by Helio Tedesco Silva Jr.
    Silva HT
    Drugs; 2007; 67(13):1944-5. PubMed ID: 17722963
    [No Abstract]   [Full Text] [Related]  

  • 38. COVID-19 and the digestive system: protection and management during the SARS-CoV-2 pandemic.
    Crespo J; Iglesias-García J; Hinojosa Del Val JE; García García F; Gil de Miguel Á; Fernández Carrillo C; Ampuero J; Pérez-Cuadrado Martínez E
    Rev Esp Enferm Dig; 2020 May; 112(5):389-396. PubMed ID: 32338017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary tacrolimus (FK506) therapy and the long-term risk of post-transplant lymphoproliferative disease in pediatric liver transplant recipients.
    Cacciarelli TV; Reyes J; Jaffe R; Mazariegos GV; Jain A; Fung JJ; Green M
    Pediatr Transplant; 2001 Oct; 5(5):359-64. PubMed ID: 11560756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mycophenolate mofetil rescue therapy in liver transplant recipients.
    Gavlik A; Goldberg MG; Tsaroucha A; Webb MG; Khan RT; Weppler D; Nery JR; Khan MF; Zucker K; Viciana AL; Miller JA; Tzakis AG
    Transplant Proc; 1997; 29(1-2):549-52. PubMed ID: 9123124
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.